Advertisement
Screener

TELA Bio, Inc. (TELA) Graph

2.8 / 5 stars · 68/120 Roast Me

TELA Revenue Flow

TELA Graph summary

TELA Bio, Inc. (TELA). Quarter ended 2026-06-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.

How TELA Bio, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.02B $0.01B$0.01B $0.02B$-0.01B$0.00B$0.02B$0.00B$-0.01B$0.00B$0.00B$-0.01B Revenue from contracts with customers, excluding assessed tax$0.02BDeclared revenue$0.02BDeclared gross profit$0.01B Total gross profit$0.01BOperating expenses$0.02BOperating income$-0.01BResearch and development$0.00BSelling and marketing$0.02BGeneral and administrative$0.00BOther expense, net$0.00BPre-tax income$-0.01BIncome tax$0.00BNet income$-0.01B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
InspireMD, Inc. (NSPR)$0.033B
Advertisement